These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 15510896

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F, Arikan C, Sertoz RY, Nart D, Aydogdu S, Yagci RV.
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [Abstract] [Full Text] [Related]

  • 5. Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better.
    Choe BH, Lee JH, Jang YC, Jang CH, Oh KW, Kwon S, Hyun MC, Ko CW, Lee KS, Lee WK.
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):92-8. PubMed ID: 17204960
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B.
    Sokal EM, Kelly DA, Mizerski J, Badia IB, Areias JA, Schwarz KB, Vegnente A, Little NR, Gardener SD, Jonas MM.
    Hepatology; 2006 Feb; 43(2):225-32. PubMed ID: 16440364
    [Abstract] [Full Text] [Related]

  • 8. Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.
    Jonas MM, Little NR, Gardner SD, International Pediatric Lamivudine Investigator Group.
    J Viral Hepat; 2008 Jan; 15(1):20-7. PubMed ID: 18088241
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment results of chronic hepatitis B in children: a retrospective study.
    Selimoğlu MA, Ertekin V, Karabiber H, Turgut A, Gürsan N.
    Turk J Pediatr; 2010 Jan; 52(4):360-6. PubMed ID: 21043380
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment.
    Sarin SK, Kumar M, Hissar S, Sharma BC.
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):374-80. PubMed ID: 16911934
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy.
    Byun KS, Kwon OS, Kim JH, Yim HJ, Chang YJ, Kim JY, Yeon JE, Park JJ, Kim JS, Bak YT, Lee CH.
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1838-42. PubMed ID: 16336441
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A long-term observation and follow-up for patients with HBeAg/Anti-HBe seroconversion after lamivudine treatment].
    Wu JL, Li SG, Wen FY, Yang XY, Zhou HJ.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):297-9. PubMed ID: 15850522
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H.
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.